Pluri Inc. Payments for (Proceeds from) Other Investing Activities
Pluri Inc. (PLUR) reported Payments for (Proceeds from) Other Investing Activities of $3.00 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2013-11-05
- Pluri Inc. payments for (proceeds from) other investing activities for the quarter ending 2013-09-30 was $3.00K.
- Pluri Inc. payments for (proceeds from) other investing activities for the quarter ending 2013-03-31 was -$488.48K, a 193.05% decline year-over-year.
- Pluri Inc. payments for (proceeds from) other investing activities for the quarter ending 2012-12-31 was $299.48K.
- Pluri Inc. payments for (proceeds from) other investing activities for the quarter ending 2012-09-30 was -$300.00K, a 143.48% decline year-over-year.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month |
|---|---|---|---|
| 2013-09-30 | $3.00K 10-Q · filed 2013-11-05 | ||
| 2013-03-31 | -$488.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | -$189.00K derived: sum of 2 quarters · filed 2013-05-08 | -$489.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $299.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | -$521.00 10-Q · filed 2013-01-31 | |
| 2012-09-30 | -$300.00K 10-Q · filed 2013-11-05 | ||
| 2012-03-31 | $524.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | -$164.00K derived: sum of 2 quarters · filed 2013-05-08 | $526.00K 10-Q · filed 2013-05-08 |
| 2011-12-31 | -$688.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | $1.01K 10-Q · filed 2013-01-31 | |
| 2011-09-30 | $690.00K 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |